000 | 01973 a2200577 4500 | ||
---|---|---|---|
005 | 20250516194525.0 | ||
264 | 0 | _c20141217 | |
008 | 201412s 0 0 eng d | ||
022 | _a1875-8908 | ||
024 | 7 |
_a10.3233/JAD-2014-132057 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrammas, Paula | |
245 | 0 | 0 |
_aA new paradigm for the treatment of Alzheimer's disease: targeting vascular activation. _h[electronic resource] |
260 |
_bJournal of Alzheimer's disease : JAD _c2014 |
||
300 |
_a619-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aAmyloid beta-Protein Precursor _xgenetics |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntifibrinolytic Agents _xpharmacology |
650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
650 | 0 | 4 |
_aBlood Vessels _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aPresenilin-1 _xgenetics |
650 | 0 | 4 |
_aPyrroles _xpharmacology |
650 | 0 | 4 |
_aReaction Time _xdrug effects |
650 | 0 | 4 | _aSunitinib |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVitamin K 3 _xpharmacology |
700 | 1 | _aMartinez, Joseph | |
700 | 1 | _aSanchez, Alma | |
700 | 1 | _aYin, Xiangling | |
700 | 1 | _aRiley, Jarred | |
700 | 1 | _aGay, Dylan | |
700 | 1 | _aDesobry, Katherine | |
700 | 1 | _aTripathy, Debjani | |
700 | 1 | _aLuo, Jinhua | |
700 | 1 | _aEvola, Marianne | |
700 | 1 | _aYoung, Alice | |
773 | 0 |
_tJournal of Alzheimer's disease : JAD _gvol. 40 _gno. 3 _gp. 619-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3233/JAD-2014-132057 _zAvailable from publisher's website |
999 |
_c23523028 _d23523028 |